ABSTRACT Leptospirosis has been recognized as the disease of the dogs. The prevention of canine leptospirosis can block the transmission of the etiological agent to humans. Commercial vaccines prevent not only clinical leptospirosis but also the renal carrier state in dogs. Thus in this present investigation, the humoral immune response of the vaccinated dogs with the multivalent vaccine (Megavac-6) was analyzed. Enzyme linked immunosorbent assay (ELISA) with preparations of 2 whole cell lysate, 2 leptospiral LPS, 4 purified recombinant proteins were used to test sera from 30 dogs vaccinated with MEGAVAC-6, a commercial vaccine practiced by the animal husbandary Departments in Tamilnadu. All 30 sera were positive by ELISA with whole cell lysate of Canicola and Icterohaemorrhagiae, and ELISA with Canicola LPS, Icterohaemorrhagiae LPS; antibody titres ranged from 20 to ≥10,240. Although there was less frequent reactivity of sera with recombinant antigens, antibodies to LipL32 and LigA were detected in 25 (83.3%) serum samples. Less frequent reactivity was noted when recombinant GroEl, LK73.5 antigens were included separately in ELISAs. The highest MAT titre was observed against the serovar Canicola and Icterohaemorrhagiae. The more reactivity against LPS may be due to the dominance of serovar specific leptospiral LPS, which may be the dominant immunogenic antigen in inactivated bivalent leptospiral vaccines. Eventhough LPS is the dominant antigen. It is serovars specific and hence recommends the incorporation of the locally circulating serovars in vaccine for its efficient use. The efficiency at this point can be increased by the use of subunit vaccines rather than recombinant proteins as such. The present study has proposed certain epitopes with increased antigenic potency.
Cite this paper
K. Natarajaseenivasan, C. Lakshmi Priya, S. Vanithamani, S. Shanmughapriya and S. Anandhagiri, "Humoral Immune Response of Inactivated Bivalent Leptospira Vaccine among Dogs in Tiruchirappalli, Tamilnadu, India," World Journal of Vaccines, Vol. 2 No. 2, 2012, pp. 85-90. doi: 10.4236/wjv.2012.22011.
 P. N. Levett, “Leptospirosis: A Forgotten Zoonosis,” Clinical and Applied Immunology Reviews, Vol. 4, No. 6, 1994, pp. 435-448. doi:10.1016/j.cair.2004.08.001
 World Health Organisation, “Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control 2003,” WHO Library Cataloguing-in Publication Data, Geneva, 2003.
 N. B. Vanasco, M. D. Sequeira, G. Sequeira and H. D. Tarabla, “Associations between Leptospiral Infection and Seropositivity in Rodents and Environmental Characteristics in Argentina,” Preventive Veterinary Medicine, Vol. 60, No. 3, 2003, pp. 227-235.
 T. Meeyam, P. Tablerk, B. Petchanok, D. Pichpol and P. Padungtod, “Seroprevalence and Risk Factors Associated with Leptospirosis in Dogs,” Southeast Asian Journal of Tropical Medicine and Public Health, Vol. 37, No. 1, 2006, pp. 148-153.
 C. O. R. Everard, G. M. Fraser-Chanpong, L. J. Bhagwandin, M. W. Race and A. C. James, “Leptospires in Wildlife from Trinidad and Grenada,” Journal of Wildlife Disease, Vol. 19, No. 3, 1983, pp. 192-199.
 C. O. R. Everard, G. M. Fraser-Chanpong, A. C. James and L. V. Butcher, “Serological Studies on Leptospirosis in Livestock and Chickens from Grenada and Trinidad,” Transactions of the Royal Society of Tropical Medicine and Hygiene, Vol. 79, No. 6, 1985, pp. 859-864.
 S. Faine, “Leptospira and Leptospirosis,” CRC Press, Boca Raton, 1994.
 H. L. B. M. Klaasen, M. J. C. H. Molkenboer, M. P. Vrijenhoek and M. J. Kaashoek, “Duration of Immunity in Dogs Vaccinated against Leptospirosis with a Bivalent Inactivated Vaccine,” Veterinary Microbiology, Vol. 95, No. 1-2, 2003, pp. 121-132.
 R. T. Trevejo, J. G. Rigau-Perez, D. A. Ashford, E. M. McClure, C. Jarquin-Gonzales, J. J. Amador, J. O. De los Reyes, A. Gonzales, S. R. Zaki, W. J. Shieh, R. G. McLean, R. S. Nasci, R. S. Weyant, C. A. Bolin, S. L. Bragg, B. A. Perkins and R. A. Spiegel, “Epidemic Leptospirosis Associated with Pulmonary Hemorrhage Nicaragua, 1995,” Journal of Infectious Diseases, Vol. 178, 1998, No. 5, pp. 1457-1463. doi:10.1086/314424
 I. Ferguson, “A European Perspective on Leptospirosis,” Microbiology Europe, 1994, pp. 8-11.
 V. Marshall, “Efficacy of Leptospira Vaccine,” Journal of American Veterinary Medical Association, Vol. 183, No. 1, 1983, pp. 33-34.
 J. S. Wohl, “Canine leptospirosis,” Compendium and Veterinary Technician, Vol. 18, No. 11, 1996, pp. 1215-1241.
 J. N. Saddler and A. C. Wardlaw, “Extraction, Distribution and Biodegradation of Bacterial Lipopolysaccharides in Estuarine Sediments,” Antonie van Leeuwenhoek, Vol. 46, No. 1, 1980, pp. 27-39. doi:10.1007/BF00422226
 M. Dubois, K. A. Gilles, J. K. Hamilton, P. Rebers and F. Smith, “Colorimetirc Methods for the Determination of Sugars and Related Substances,” Annals of Chemistry, Vol. 28, No. 3, 1956, pp. 350-356.
 K. Natarajaseenivasan and S. Ratnam, “Seroprevalence of Leptospiral Infection in an Agricultural Based Village in Tamilnadu,” Cheiron, Vol. 26, No. 5-6, 1997, pp. 80-83.
 S. Ratnam, S. Subramanian and T. Sundararaj, “Evidence of Leptospiral Antibodies among Domestic Animals in Madras City,” Cheiron, Vol. 12, 1983, No. 4, pp. 176-179.
 W. J. Terpstea, G. S. Lighthart and C. J. Schoone, “ELISA for the Detection of Specific IgM and IgG in Human Leptospirosis,” Journal of General Microbiology, Vol. 131, No. 2, 1985, pp. 377-385.
 Y. El-Manzalawy, D. Dobbs and V. Honavar, “Predicted Linear B-Cell Epitopes Using String Kernels,” Journal of Molecule Recognition, Vol. 21, No. 4, 2008, pp. 243-255.
 S. K. Srivastava, S. Sankar, H. M. Harshan and S. R. Somarajan, “Evaluation of a Recombinant LigB Protein of Leptospira Interrogans Serovar Canicola in an Enzyme-Linked Immunosorbent Assay for the Serodiagnosis of Bovine Leptospirosis,” Research in Veterinary Science, Vol. 88, No. 3, 2010, pp. 375-378.